Spinal muscular atrophy care has evolved with disease-modifying drugs, enabling patients to live longer and...
Blood biomarkers are revolutionizing early Alzheimer detection, with a new P‑tau217 blood test matching PET...
Spinal muscular atrophy treatment breakthroughs extend lives, but healthcare systems struggle to adapt to new...
Discover the latest spinal muscular atrophy treatment options, including nusinersen and onasemnogene abeparvovec, for patients...
Takeda's oveporexton approved for narcolepsy type 1 treatment as first medicine to target orexin signaling...
Lennox-Gastaut syndrome presents complex care challenges. Learn about treatment advancements and how to plan for...
The FDA will review tau PET imaging agent MK-6240 on August 13, seeking better Alzheimer...
High-dose NAC treatment shows promise in reducing brain damage markers in progressive MS patients, according...
New tools and strategies are transforming alzheimer diagnosis despite cost barriers. Learn about the latest...
New Alzheimer’s blood test shows high reliability matching PET scans, advancing early detection for cognitive...